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With the aid of the recently developed Sensor reactor system, a series of three
subsequent 13C labeling experiments was performed mirroring the L-phenylalanine
(L-Phe) production phase of a recombinant E. coli strain that was cultivated under
industry-like conditions in a 300 L bioreactor. On the basis of the data from NMR
labeling analysis, three subsequent flux patterns were successfully derived monitoring
the L-Phe formation during an observation window from 14 to 23.3 h process time.
Linear programming was performed to identify optimal flux patterns for L-Phe
formation. Additionally, flux sensitivity analysis was used to identify the most
promising metabolic engineering target. As a result, high rates of phosphoenolpyruvate
(PEP) to pyruvate (PYR) conversion were identified as the most important reason for
deterioration of the L-Phe/glucose yield from 20 to finally 11 mol %. Considering the
characteristics of the enzyme kinetics involved, the working hypothesis was formulated
that phosphoenolpyruvate synthase activity was increasingly hampered by rising
oxaloacetate and 2-oxoglutarate concentrations, while at the same time pyruvate kinase
activity arose due to activation by fructose 1,6-diphosphate. Hence, pps overexpression
should be performed to optimize the existing production strain.
Introduction
The production of aromatic amino acids, corresponding
pathway intermediates, or derivatives thereof is without
doubt of great commercial importance (Frost and Lievense,
1994; Bongaerts et al., 2001; Schmid et al., 2001; Bon-
gaerts et al., 2001; Drauz et al., 2002). Several production
approaches have been published using, for instance,
recombinant E. coli strains. Examples are the production
of pathway intermediates such as 3-dehydroshikimic acid
(Li et al., 1999), shikimic acid (Chandram et al., 2003),
chorismate derivatives such as trans-2,3-cyclohexanediole
(Franke et al., 2003a), or trans-3,4-cyclohexanediole
(Franke et al., 2003b) and the final pathway products
L-tryptophane, L-tyrosine, and L-phenylalanine (Bon-
gaerts et al., 2001; Drauz et al., 2002; Gerigk et al., 2002).
Among these products, L-phenylalanine currently repre-
sents the largest economical market with 11 000 to
12 000 tons per year and a product price of 20-40 US$/
kg depending on the product purity (Bongaerts et al.,
2001). In the case of L-phenylalanine, the majority is used
for the production of the artificial sweetener aspartame,
for instance, in the “Thermolysine” process at DSM, The
Netherlands (Schmid et al., 2001).
Motivated by these promising commercial perspectives,
several studies were previously performed investigating
the optimum supply for the pathway precursors D-eryth-
rose-4-phosphate (E4P) and phosphoenolpyruvate (PEP).
To ensure a sufficient E4P availability, transaldolase (tal)
(Lu and Liao, 1997) and/or transketolase (tktA) over-
expression was studied (Draths et al., 1992) and subse-
quently combined with phosphoenolpyruvate synthase
(pps) overexpression (Patnaik and Liao, 1994; Patnaik
et al., 1995; Berry, 1996; Gosset et al., 1996; Yi et al.,
2002; Chandram et al., 2003) or alternative glucose
uptake systems in phosphotransferase system (pts)-
negative strains (Berry, 1996; Gosset et al., 1996; Flores
et al., 1996; Chen et al., 1997). In addition, Csr (carbon
storage regulator) disrupted strains were used to ensure
a sufficient PEP supply (Tatarko and Romeo, 2001).
Despite the invaluable importance of these results for
the optimization of the aromatic amino acid precursor
supply, detailed (13C-based) flux analysis has not yet been
used to elucidate intracellular flux redistributions in
strains producing aromatic amino acid pathway inter-
mediates or final products such as L-phenylalanine. So
far, flux analysis has been applied to estimate (theoreti-
cal) optimum flux distributions in DAHP (3-desoxy-
arabino-heptulosonate-7-phosphate)-producing strains
(Patnaik and Liao, 1994; Patnaik et al., 1995), which even
achieved a glucose-to-DAHP conversion with theoretical
yield (Liao et al., 1996). Also, the effect of pts inactivation
for DAHP production was studied (Flores et al., 2002).
However, one should consider that metabolic flux analy-
sis for L-phenylalanine producers significantly differs
from the DAHP studies because of the second PEP
molecule needed for L-phenylalanine biosynthesis. It is
also noteworthy that all studies were limited to shake
flasks or small, lab-scale bioreactors that obviously did
not represent industry-like production conditions in
large-scale bioreactors.
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Hence it is the aim of this study to apply detailed 13C-
based metabolic flux analysis to an L-phenylalanine (L-
Phe)-producing E. coli strain. With the aid of a recently
developed Sensor reactor (El Massaoudi et al., 2003;
Drysch et al., 2003a; Drysch et al., 2003b), carbon flux
distributions in the L-Phe producing E. coli 4pF81 strain
were studied under realistic, 300 L-scale production
conditions, described elsewhere (Gerigk et al. 2002,
Ru¨ffer et al., 2003). A series of carbon flux maps will be
presented on the basis of 13C labeling experiments,
identifying changing intracellular flux distributions dur-
ing the L-phenylalanine production phase. The series of
flux maps is compared to the theoretical, optimum flux
distribution. Additionally, a flux sensitivity analysis is
presented and a working hypothesis for further produc-
tion strain optimization is derived.
Material and Methods
Strain and Cultivation Conditions. The L-Phe
production strain E. coli 4pF81, presented elsewhere
(Ru¨ffer et al., 2003) based on E. coli K 12 LJ110
(Zeppenfeld et al., 2000) was used. The genotype was E.
coli LJ110 ¢(pheA tyrA aroF) pJF119EH aroF pheAfbr
aroB aroL. The genes pheA (encodes chorismate mutase/
prephenate dehydratase), tyrA (encodes chorismate mu-
tase/prephenate dehydrogenase), and aroF (encodes ty-
rosine feedback-inhibited DAHP synthase) were deleted
in the chromosome. The strain was tyrosine auxotrophic
to prevent carbon flux into tyrosine synthesis. The
plasmid pJF119EH carried the genes aroF, pheAfbr
(resistant against feedback inhibition by L-phenylala-
nine), aroB (encodes 3-dehydroquinate synthase), and
aroL (encodes shikimate kinase II). This plasmid-encoded
gene overexpression was performed to avoid an unwanted
accumulation of pathway intermediates upstream of the
enzymes encoded by the above-mentioned genes. The
genes were under control of the IPTG-inducible Ptac
promoter. Ampicillin resistance was plasmid encoded as
a selection marker for plasmid-containing cells.
For shaking flask cultivations, the following medium
was used: 0.3 g/L MgSO4â7H2O, 0.015 g/L CaCl2â2H2O,
3.0 g/L KH2PO4, 12 g/L K2HPO4, 0.1 g/L NaCl, 5.0 g/L
(NH4)2SO4, 0.075 g/L Fe(SO4)2â7H2O, 1.0 g/L Na-citrate,
1.5 mL/L trace element solution, 0.0075 g/L vitamin B1
(thiamine HCl), 0.08 g/L tyrosine, 5.0 g/L glucoseâH2O,
0.1 g/L ampicillin. The trace element solution consisted
of: 2.0 g/L Al2(SO4)3â18H2O, 0.75 g/L CoSO4â7H2O, 2.5
g/L CuSO4â5H2O, 0.5 g/L H3BO4, 24 g/L MnSO4, 3.0 g/L
Na2MoO4â2H2O, 2.5 g/L NiSO4â6H2O, 15 g/L ZnSO4â
7H2O.
Four shaking flasks with 250 mL of culture were used
to inoculate the 30 L bioreactor. The preculture medium
of the 30 L bioreactor was the same as the shaking flask
medium. E. coli was cultivated at pH 6.5 and 37 °C with
0.5 bar overpressure (aeration rate: 1 vvm). The dis-
solved oxygen level was controlled at 30%, ensuring
aerobic conditions. After OD620  3 was reached in the
30 L bioreactor, a liquid volume of 11 L was pumped into
the 300 L bioreactor. Here, the same medium was used
as before except for higher concentrations of Fe(SO4)2â
7H2O (0.1125 g/L), Na-citrate (1.5 g/L), glucoseâH2O
(15.0 g/L), and trace element solution (1.5 mL/L).
When E. coli 4pF81 was cultivated in the 300 L fed-
batch process, a tyrosine-containing feed (20 mL/min, 25
g/L, dissolved in 5% NH3 to increase its solubility) was
started at the beginning of the exponential growth phase
(OD620  8) lasting until OD  80 was reached. After this,
the feed was drastically reduced to 1 mL/min until the
end of the fermentation to fulfill only maintenance
demands of the cells. The glucose feed profile (containing
600 g/L glucoseâH2O) was based on previous experiments
published elsewhere (Ru¨ffer et al., 2003) and was manu-
ally controlled such that no significant glucose accumula-
tion occurred in the production process. All feed profiles
of the Sensor reactor were similar to the production
process but automatically scaled down (with the aid of
LabView process control) with respect to the current
liquid volume ratio of the two processes. In addition a
reduced tyrosine concentration of 2.5 g/L was used in the
Sensor reactor feed to allow an accurate feeding. After
OD620 10-15 was achieved, 100 íM IPTG was added for
induction. Fermentation details can be found elsewhere
(Gerigk et al., 2002).
Sensor Reactor System. The 1 L Sensor reactor
(controlling device: Infors, Basel, Switzerland) was
installed close to the 300 L production reactor (Chemap,
Volketswil, Switzerland) and connected to the production
process in master/slave mode. Moving averages of five
on-line measurements of dissolved oxygen (DO), pH,
temperature, pressure, and aeration of the production
reactor were used as set points for the Sensor reactor
via a LabView (National Instruments Corporation, Aus-
tin, TX)-based process control system (for details, see El
Massaoudi et al., 2003). pH control was realized by
addition of 10% NH4OH.
At the beginning of each labeling period, a well-defined
inoculation sample of 1 L was automatically taken out
of the production process via a special inoculation unit.
Subsequently, 1-13C-labeled glucose was pulsed into the
Sensor reactor, and the scaled-down feeding profile,
containing 1-13C glucose, was started (for labeling details,
see below). The Sensor reactor ran in parallel to the
production process for 2.5 to 3 h, thus ensuring a
sufficient labeling pattern in the supernatant. After one
labeling period was finished, the Sensor reactor was
completely emptied, cleaned via over-pressurized aera-
tion and steam streaming (for details see El Massaoudi
et al., 2003), and prepared for the next labeling experi-
ment monitoring a subsequent phase of the production
process. In general, the experimental carbon balance was
closed at about 92%.
Labeling and Sampling. Immediately before each
labeling experiment, the current glucose concentration
of the production process was measured and the liquid
volume containing 140 g/L of [1-13C] glucose (99% atom
enrichment, Cambridge Isotope Laboratories, Andover,
MA) was calculated and subsequently pulsed into the
Sensor reactor (with the aid of an automatic pulsing
device, El Massaoudi et al., 2003) to ensure a 25% content
of labeled glucose. Then, the scaled-down (see above)
glucose feed of the Sensor reactor was started, containing
the same fraction (25%) of labeled glucose. Following this
procedure, the 13C enrichment was kept constant at 25%
throughout the entire labeling period (see also Table 1).
Samples were taken in 20 min intervals from the Sensor
reactor and from the production process. The samples
were centrifuged, and the supernatant was stored at -20
°C for subsequent HPLC and NMR analysis.
Sample and Labeling Analysis. Glucose was mea-
sured by using an enzymatic analysis kit (Boehringer,
Mannheim, Germany) with hexokinase (EC 2.7.1.1.) and
glucose-6-phosphate-dehydrogenase (EC 1.1.1.49). Bio-
mass dry weight was determined gravimetrically and
showed a linear relationship with photometric turbidity
measurements at 620 nm. Amino acids were analyzed
by HPLC after derivatization with ortho-phthaldialde-
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hyde (OPA), separation on a reverse-phase column, and
detection of the fluorescence of the OPA derivative
(Ogden and Fo¨ldi, 1992). Organic acids were measured
by using an Aminex HPX-87H column (Biorad, Munich,
Germany) eluted at 40 °C with 0.2 N H2SO4. The UV
absorption was detected at 254 nm.
13C NMR spectra (with proton decoupling) were re-
corded at 90.56 MHz in 5 mm tubes on a Bruker AMX
360. Prior to measurements, samples were lyophilized
and redissolved in D2O at twice the original concentra-
tion. A small amount of EDTA was added (5 mg/mL) to
chelate the metal ions. To eliminate NOEs and ensure
quantitative results, the decoupler was switched off
during the 45 s recycling delay (5 times the longest T1).
Acquisition parameters: spectral width 240 ppm; pulse
width 6 ís (90° flip angle); data size 80K; acquisition time
1.88 s; number of scans 4800. A line broadening of 1 Hz
was applied, and 128K data were used for the processed
spectra. The enrichments were calculated from the
integrals of the individual carbon atoms, where positions
2, 4, and 6 + 8 gave identical integral values and were
assumed to not be enriched.
Modeling and Sensitivity Analysis. For calculation
of the intracellular fluxes, it was assumed that the Sensor
reactor was in a quasisteady state, i.e., the intra- and
extracellular fluxes were constant over the timespan of
the labeling experiment leading to equilibrated labeling
patterns in the metabolite pools. The measured 13C
enrichments of the supernatant pools had to be corrected
due to the dilution by nonlabeled metabolites that were
produced before the labeling experiment (see Table 4).
The enrichment (x) [%] achieved during the labeling
period was calculated from the 1H NMR measurements
(y) [%] with the molar fraction (p) [mol/mol %] of produced
phenylalanine following the eq 1:
Extracellular fluxes such as glucose uptake, product
formation, and CO2 production were calculated from
concentration measurements and corrected for dilution
Table 1. Flux Estimations of the 13C-Based Flux Analysisa
experiment A, 14-16.8 h experiment B, 17.2-20 h experiment C, 20.5-23.3 h
reaction flux [mM/h] error [mM/h] flux [mM/h] error [mM/h] flux [mM/h] error [mM/h]
upt1 17.52 0.30 14.13 0.30 13.43 0.30
upt2 52.08 0.30 42.31 0.30 39.47 0.30
emp1 31.79 8.50 34.62 8.98 49.90 26.27
emp2 52.29 2.85 45.60 3.01 49.90 8.76
emp3 52.29 2.85 45.60 3.01 49.90 8.76
emp4 197.77 2.94 91.36 3.09 96.81 8.79
ppp1 37.81 8.51 21.82 8.99 3.00 26.27
ppp2 20.50 5.67 10.99 5.99 0.00 17.51
ppp3 17.31 2.84 10.84 3.00 3.00 8.76
ppp4 3.19 2.84 0.15 3.00 -3.00 8.76
ppp5 17.31 2.84 10.84 3.00 3.00 8.76
ppp6 17.31 2.84 10.84 3.00 3.00 8.76
tcc 79.27 3.00 69.65 3.15 84.63 8.81
ana1 0.26 0.02 0.33 0.02 0.2 0.02
ura 0.26 0.02 0.33 0.02 0.2 0.02
dahp shi phe 14.12 0.20 10.69 0.20 5.99 0.2
CO2 aux 289.50 3.11 241.14 3.09 262.67 3.09
a Because the labeling patterns in PEP and PYR could not be distinguished, a common PEP/PYR pool was used for modeling. The flux
emp5 shown in Figure 2 is not included in the 13C model; it can only be identified later by stoichiometric constraints. The reactions and
atom transitions are shown in Table 5. upt1 and upt2 code for the uptake of labeled and nonlabeled glucose, respectively, allowing the
conclusion that the prechosen aim of 25% 13C enrichment was well achieved.
Table 2. Stoichiometric Matrix Used for Linear Programminga
reactionsmetabolite
constraints pts emp1 emp2 emp3 emp4 emp5 ppp1 ppp2 ppp3 ppp4 ppp5 ppp6 tca dahp shi phe resp fut thy
G6P 1 -1 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0
F6P 0 1 -1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0
FBP 0 0 1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
GAP 0 0 0 2 -1 0 0 0 0 1 1 -1 0 0 0 0 0 0 0
PEP -1 0 0 0 1 -1 0 0 0 0 0 0 0 -1 0 -1 0 0 0
PYR 1 0 0 0 0 1 0 0 0 0 0 0 -1 0 0 0 0 0 0
Ru5P 0 0 0 0 0 0 1 -1 -1 0 0 0 0 0 0 0 0 0 0
X5P 0 0 0 0 0 0 0 1 0 -1 -1 0 0 0 0 0 0 0 0
Ri5P 0 0 0 0 0 0 0 0 1 0 -1 0 0 0 0 0 0 0 0
E4P 0 0 0 0 0 0 0 0 0 -1 0 1 0 -1 0 0 0 0 0
S7P 0 0 0 0 0 0 0 0 0 0 1 -1 0 0 0 0 0 0 0
DAHP 0 0 0 0 0 0 0 0 0 0 0 0 0 1 -1 0 0 0 0
SHI 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 -1 0 0 0
NADH 0 0 0 0 1 0 0 0 0 0 0 0 3 0 0 0 -1 0 -1
NADPH 0 0 0 0 0 0 2 0 0 0 0 0 0 0 -1 0 0 0 1
ATP 0 0 -1 0 1 1 0 0 0 0 0 0 0 0 0 -1 1,8 -1 0
Upt)1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
a Linear programming approach is based on the assumption of a constant P/O ratio (constant NADH/ATP conversion resp at 1.8).
Balances for cometabolites NADPH, NADH, and ATP are “open”. Ample ATP can be consumed by the futile reaction fut. Reactions of the
tricarboxylic cycle were lumped to tca, which is motivated by the lacking efflux rates into the amino acid synthesis during L-Phe production
with tyrosine-limited, nongrowing cells. It is noteworthy that the stoichiometric model possesses two degrees of freedom, which are fulfilled
by the maximization constraints optimum L-Phe flux and minimum futile cycle activity.
y ) px + (1 - p)0.011 (1)
708 Biotechnol. Prog., 2004, Vol. 20, No. 3
due to glucose feeding and sampling (see Table 4). 13C
flux estimation was carried out using the software 13C
FLUX (Mo¨llney et al., 1999; Wiechert et al., 1999). The
metabolic model included reactions from glycolysis, pen-
tose phosphate pathway and the tricarboxylic acid cycle
(see Table 5). The glyoxylic shunt was assumed to be
inactive under the aerobic experimental conditions. Ac-
cording to Fischer and Sauer (2003) and Peekhaus and
Conway (1998), the Entner-Doudoroff (ED) pathway
only plays a minor role in (wild-type) E. coli central
metabolism and therefore was neglected in the model.
The pools PEP and PYR as well as oxalacetate and
malate were lumped, leading to a pts decoupling from
the PEP/PYR conversion. The reactions of the L-Phe
production pathway and the respective C-atom transi-
tions are also shown in Table 5. Fluxes were estimated
by using an evolutionary optimization, which was fol-
lowed by a local optimization (optimizers are CooolEvoAl-
pha and CooolBFGSAlpha from the Coool library, http://
coool.mines.edu/).
Linear Programming. A stoichiometric approach can
be used to determine the theoretical, optimal flux dis-
tribution for maximum phenylalanine production. It was
assumed that no growth occurred during the production
phase, i.e., there were no fluxes into the biomass. The
model included metabolites of the glycolysis (G6P, FBP,
PEP, PYR), pentose-phosphate (Ru5P, RiP, S7P, E4P),
and aromatic amino acid (DAHP, SHI) pathways. Me-
tabolites of the tricarboxylic acid cycle were not balanced
but lumped into one reaction step. Co-Metabolites such
as NADH, NADPH, and ATP were included with “open”
balances; for instance futile cycling (fut) was allowed as
a free flux to consume ample ATP. It was assumed that
the L-Phe-producing strain possessed an active PEP
synthase (Pps, represented by reaction emp5) and a
transhydrogenase (thy) reaction enabling the proton
transfer from NADH to NADPH. In total, the model
consisted of 16 balanced metabolites and 19 reactions
(Table 1) signifying three degrees of freedom. To cover
three degrees, the input flux (pts) was set to one, the
production flux was maximized, and futile cycling (fut)
was minimized. Furthermore, some flux limits were given
such as respiration, TCA, and futile cycling had to be
positive (resp, tca, fut g 0).
Sensitivity Analysis. To qualify the sensitivity of the
flux distributions, a linear programming approach was
followed. The basic idea was to derive flux sensitivity
data that were not as dependent on the choice of free
fluxes as in the classical approach of Delgado and Liao
(1997). Based on the experimentally determined meta-
bolic fluxes, the glucose uptake was set constant together
with one of the interesting fluxes such as emp5, ppp1,
ppp4, or ppp6. Use of the constraint of L-Phe flux
Table 3. Measured Extracellular Fluxes Used for
Metabolic Flux Analysisa
fluxes [mmol/Lh]
upt1 upt2 L-Phe CO2 uracil
phase A 17.53 52.09 14.12 253.6 0.26
phase B 14.13 42.32 10.69 238.1 0.33
phase C 13.48 39.52 5.96 209.2 0.2
aupt1 and upt2 indicate the 1-13C-labeled and the nonlabeled
glucose uptake.
Table 4. Label Enrichments at Certain C-Positions of
L-Phea
raw data corrected data
C3 [%] C5 + C9 [%] p [%] C3 [%] C5 + C9 [%]
phase A 4.50 3.90 39.26 9.76 8.23
phase B 3.80 3.10 23.66 12.51 9.55
phase C 3.20 2.60 11.83 18.86 13.78
aCorrections due to signal dilution are included. p represents
the fraction of L-Phe produced during the labeling experiment
compared to the total amount found in the supernatant. The
corrected values were used for 13C-based flux estimation.
Table 5. Model Reactions and Atom Transitions for 13C Flux Analysisa
name reaction C-atom transition
upt1 Gluc13C > G6P #ABCDEF > #ABCDEF
upt2 GlucNat > G6P #ABCDEF > #ABCDEF
emp1 G6P > F6P #ABCDEF > #ABCDEF
emp2 F6P > FBP #ABCDEF > #ABCDEF
emp3 FBP > GAP + GAP #ABCDEF > #CBA + #DEF
emp4 GAP > PEP/PYR #ABC > #ABC
ppp1 G6P > CO2 + Ru5P #ABCDEF > #A + #BCDEF
ppp2 Ru5P > 5P #ABCDE > #ABCDE
ppp3 Ru5P > Ri5P #ABCDE > #ABCDE
ppp4 X5P + E4P > GAP + F6P #ABCDE + #abcd > #CDE + #ABabcd
ppp5 X5P + Ri5P > S7P + GAP #ABCDE + #abcde > #ABabcde + #CDE
ppp6 GAP + S7P > E4P + F6P #ABC + #abcdefg > #defg + #abcABC
tcc1 PEP/Pyr > AcCoA + CO2 #ABC > #BC + #A
tcc2 AcCoA + MAL/OAA > ICIT #AB + #abcd > #dcbaBA
tcc3 ICIT > AKG + CO2 #ABCDEF > #ABCEF + #D
tcc4 AKG > SUC + CO2 #ABCDE > #BCDE + #A
tcc5a SUC > MAL/OAA #ABCD > #ABCD
tcc5b SUC > MAL/OAA #ABCD > #DCBA
ana1 PEP/PYR + CO2 > MAL/OAA #ABC + #a > #ABCa
ura MAL/OAA + CO2 > Uracil + CO2 #ABCD + #a > #CBAa + #D
Uracilaux Uracil > UracilAux #abcd > #abcd
dahp PEP/PYR + E4P > DAHP #ABC + #abcd > #ABCabcd
shi DAHP > SHI #ABCDEFG > #BCDEFGA
pheA PEP/PYR + SHI > L-Phe + CO2 #ABC + #abcdefg > #ABCabcdef + #g
pheB PEP/PYR + SHI > L-Phe + CO2 #ABC + #abcdefg > #ABCafedcb + #g
Pheaux PHE > PHEAux #ABCEFGHIJ > #ABCEFGHIJ
CO2aux CO2 > CO2Aux #A > #A
a upt1 and upt2 indicate the 1-13C-labeled and the nonlabeled glucose uptake. It is noteworthy that pheA and pheB code for the same
synthesis step with different atom transitions because the orientation of the L-Phe ring can be mirrored. It is assumed that the two
orientations appear equally. C-atom transitions are indicated by letter sequences and represent the basis for the setup of the isotopomer
transition matrix.
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maximization allowed the rest of the metabolic network
to rearrange. Basically, the resulting flux patterns thus
represent optimum L-Phe formation rates under the
constraint that each of the subsequently fixed fluxes
emp5, ppp1, ppp4, or ppp6 could not be amplified because
of biochemical limitations or gene regulations. High L-Phe
formation rates thus indicate that the corresponding fixed
flux does not significantly hamper the reachable, optimal
L-Phe yield. On the other hand, the lowest achievable
L-Phe yield obviously corresponds to the limiting affect
of the fixed flux, thus revealing it as a promising
metabolic engineering target.
Results and Discussion
As expressed above, the study followed the idea of
analyzing changing carbon flux patterns under realistic
(300 L bioreactor) production conditions making use of
the recently presented Sensor reactor approach (El
Massaoudi et al., 2003). The following questions guided
the study:
Were real, intracellular flux distributions optimal with
respect to maximum L-Phe formation? If not, where were
the main discrepancies and how significant were they?
Did the flux patterns change during the production
period? If so, what were the main reasons?
Because previous experiments (Ru¨ffer et al., 2003)
revealed maximum product formation rates shortly after
the beginning of the tyrosine-limited production phase
(followed by a significant product formation decline), this
period was chosen to study changing intracellular flux
maps and to derive thereupon working hypotheses in-
cluding promising metabolic engineering targets for
further production strain improvement.
As indicated in Figure 1, labeling periods were realized
from 14 to 16.8 h, 17.2 to 20 h, and 20.5 to 23.3 h of
process time. Before, biomass production stopped at
OD620  80 (after 11 h) as a result of the significantly
reduced tyrosine feed as described above. Because [1-13C]
glucose was pulsed into the Sensor reactor to achieve 25%
13C glucose enrichment in the supernatant, the total
glucose level in the Sensor reactor was accordingly higher
compared to the production process following the same
course, especially during phases B and C. Differences
between the glucose curves occurred during phase A,
because glucose feeding into the Sensor reactor was too
high due to erroneous liquid volume measurements.
However, different cultivation conditions did not result
because glucose levels of both reactors ensured well-
saturated glucose uptake (Ferenci et al., 1996). Moreover,
the 13C enrichment in the Sensor reactor was not affected
because the post-pulse 13C glucose fraction in the super-
natant was the same as in the feed.
With respect to the measured metabolite concentration
courses in the supernatant, a high degree of similarity
was found. The L-Phe accumulation was almost identical
in both reactors (regression coefficient r ) 0.999). This
holds also true for the uracil synthesis (r ) 0.971)
following the â-alanine route via aspartate and oxalo-
acetate, respectively. Obviously, the two intermediates
of the aromatic amino acid pathway, 3-dehydroshikimate
(DHS) and shikimate (SHI), were produced before Sensor
reactor monitoring was started. Their production stopped
during the labeling periods, which was indicated by an
almost constant level.
In the case of the oxygen uptake rate (OUR), high
degrees of similarity were found regarding the Sensor
and the production reactor. The dissolved oxygen con-
centration (DO) was always above 30% in both processes
(data not shown), thus ensuring a nonlimited oxygen
supply. On the other hand, carbon dioxide transfer rates
(CTR) in the Sensor reactor were observed to be 15-20%
higher than in the production process during phases A
and B. However, this is an “artificial” offset that occurred
as a consequence of the maximum CO2 detection limit
that was reached in the exhaust gas analysis device used
to monitor the production process.
In summary, we have concluded that the phenomenol-
ogy of both processes was sufficiently consistent, thus
allowing both 13C-based flux analysis for the three
labeling phases and transfer of the results from the 1 L
Sensor reactor to the 300 L-scale production process.
Results of the detailed flux analysis are given in Figure
2, showing standardized fluxes (mol %) with respect to
the glucose uptake rate. Additionally, Table 1 contains
the absolute flux values (mmol L-1 h-1) with the corre-
sponding errors. As shown, most of the fluxes were
estimated with sufficient accuracy within error margins
of 5-15%, especially for the flux estimations of phases
A and B. High deviations (>25%) were found for the
reactions emp1 (glucose 6-phosphate isomerase), ppp1
(oxidative pentose phosphate pathway), and ppp2 (ribu-
lose-5-phosphate epimerase), respectively. Most presum-
ably, these deviations were caused by a lack of nucleoside
labeling information (e.g., from RNA or DNA) considering
ribose-5-phosphate (Ri5P) as the precursor, which was
not accessible using strains under nongrowing L-Phe
production conditions. This lack of additional information
becomes apparent for the flux estimates of emp1, ppp1,
and ppp2 in phase C. These fluxes were no longer
Figure 1. Comparison of phenomenological state variables such
as optical density (OD620), glucose concentration, L-phenylala-
nine concentration (L-Phe), and the oxygen uptake rate (OUR)
together with the carbon dioxide transfer rate (CTR). All
variables are shown for the production process (black symbols/
lines) and for the Sensor reactor (hollow symbols/grey lines).
Labeling experiments were started after 14, 17.2, and 20.5 h
lasting for approximately 2.5 h each.
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statistically identifiable. This observation needs to be
stressed because it illustrates the potential drawback of
a single metabolic flux analysis, which, by retrospective
analysis, could reveal the insufficiency of the experimen-
tal data measured during the prechosen observation
window. If a serial flux analysis is carried out as
presented below, potential data limitations could be
overcome, additionally uncovering systematic flux changes,
which were not accessible with a single snapshot study.
Studying the current results from 14 to 23.3 h process
time, the series of flux maps allows the conclusion that
a continuously increasing fraction of carbon was metabo-
lized via glycolysis (emp1) compared to the branching off
into the oxidative pentose phosphate pathway (ppp1). As
a consequence, transketolase (ppp4, ppp5)- and transal-
dolase (ppp6)-catalyzed fluxes of the pentose-phosphate
pathway declined significantly, giving rise to the as-
sumption that the E4P precursor supply for the aromatic
amino acid pathway decreased concomitantly. As il-
lustrated in Figure 2, the lumped PEP/PYR pool of 13C
analysis was decomposed by stoichiometric analysis,
allowing the estimation of a net flux via pyruvate kinase
and the inversely directed phosphoenolpyruvate synthase
(Pps) reaction. The serial flux analysis indicates that the
pykA and pykF encoded kinase reaction obviously in-
creasingly dominated the net flux and subsequently
amplified the flux into the tricarboxylic acid cyclic from
114 to 160 mol %. As a consequence, CO2 formation
steadily increased from 416 to 497 mol %, while at the
same time L-Phe formation rates reduced from 20 to 11
mol %. It is noteworthy, that cultivation conditions such
as pH, temperature, etc. did not change during this
period (see Figure 1). Also, the availability of the sole
carbon source glucose as well as the tyrosine supply and
oxygen availability were unchanged during the entire
observation.
To compare the observed flux distributions with a
theoretical flux map describing an optimum L-Phe pro-
duction yield, the tabulated data in Figure 2 are given.
Most strikingly, an optimum L-Phe formation of 59.7 mol
% is calculated providing that the tricarboxylic acid cycle
was inactive in nongrowing cells. As a consequence, the
Figure 2. Metabolic network and carbon flux distributions, based on 13C labeling experiments with the Sensor reactor system,
during the L-Phe production phase under tyrosine-limited conditions. Monitored are the periods 14-16.75 h (A), 17.2-20 h (B), and
20.5-23.3 h (C). All fluxes are standardized to the corresponding glucose uptake rates thus representing mol %. Reverse fluxes are
indicated by a minus sign. Because for 13C flux analysis an lumped PEP/PYR pool was used, the carbon flux from PEP to PYR was
reconstructed solely on the basis of stoichiometric constraints leading to a flux portion for pts-based PEP conversion (left box) and
the resulting net flux catalyzed by phosphoenolpyruvate synthase and pyruvate kinase (right box). The optimal flux distribution for
L-Phe production (Opt) was calculated for nongrowing cells. It is assumed that sufficient transhydrogenase activity enables the
nonlimited convertion of NADH into NADPH and vice versa. ATP is gained by respiration (1.8 ATP/NADH). The reaction names are
given in analogy to the model (Table 5).
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pts-caused PYR formation is redirected into PEP via Pps
(-100 mol %). Interestingly, only a small flux of 3.3 mol
% via the oxidative pentose-phosphate route is favored
compared to a significant transketolase activity (ppp4)
providing a high flux of -38.7 mol % into the E4P pool.
Together with the incoming transaldolase reaction (ppp6),
59.7 mol % of E4P is thus delivered into the aromatic
amino acid pathway. Interestingly, under optimum L-Phe
production conditions, a reaction cycle is built up taking
GAP and F6P from glycolysis and transferring them into
E4P and X5P; the latter is subsequently converted into
Ru5P and further metabolized via ppp3 into Ri5P and
then back into GAP. This demonstrates that all pentose-
phosphate reactions must be well equilibrated to enable
an optimum E4P supply, including transketolase and
transaldolase as well as the phosphoribose isomerase
(ppp3) and the ribulose 5-phosphate 3-epimerase (ppp2).
Figure 3 gives an overview of the differences between
measured and theoretical fluxes considering the most
important reactions of glycolysis, the pentose-phosphate
pathway, and the aromatic amino acid pathway. Even
at the beginning of the production phase, which was
previously identified as the best production period, the
flux distribution was far from optimal. The flux via
oxidative pentose phosphate pathway (ppp1) was about
50 mol % too high. Similar observations were made for
the transketolase reaction ppp4, and an even worse
situation was found for the net flux via PykA/PykF and
Pps (emp5). Against it, the transaldolase reaction ppp6
showed an almost optimum flux and kept this level,
although the measured L-Phe/glucose yield achieved only
20%, compared to the theoretical value of 59.7%. From
this, we concluded that transaldolase is probably not the
most interesting metabolic engineering target. This
statement partly contradicts previous findings of Lu and
Liao (1997) who identified a positive effect of tal over-
expression for DAHP production. However, no amplified
DAHP synthase was used in their study and DAHP
production was investigated with partly growing cells in
shaking flask cultures, which significantly differed from
the experimental conditions of Sensor reactor experi-
ments.
Figure 3 reveals that large differences occurred be-
tween (theoretical) optimal and measured fluxes for
transketolase (ppp4) and the net reaction of PykA/PykF
and Pps (emp5). The flux differences coincided with low
(insufficient) L-Phe/glucose yields, which even deterio-
rated during the course of observation. The findings are
in agreement with previous studies of Draths et al. (1992)
and Li et al., (1999), emphasizing the necessity of tktA
overexpression. Our observations also support the results
of Patnaik and Liao (1994), Patnaik et al. (1995), Berry
(1996), Gosset (1996), Yi et al. (2002), and Chandram et
al., (2003), who stressed the common overexpression of
tktA and pps to achieve an increased flux into aromatic
amino acid synthesis.
On the basis of the metabolic flux analysis presented
so far, the additional aim was followed to qualify the
observed flux deviations from the optimum such that the
identification of the most interesting metabolic engineer-
ing target was possible. Therefore, flux sensitivity analy-
sis was performed as described in the previous section.
As an example, the results of the best L-Phe production
phase (phase A) are presented in Figure 4. It is clearly
identifiable that emp5, coding for the net reaction of
PykA/PykF and Pps, represents the reaction that mostly
limited the maximum achievable L-Phe formation. In the
case of transaldolase (ppp6), its low limiting impact on
the L-Phe formation became obvious, because the theo-
retical optimum of 59.7 mol % was almost achievable
with a fixed ppp6 flux. Fixing the transketolase reaction,
encoded by ppp4, still afforded 49 mol % L-Phe flux.
Hence, emp5 should be the preferred metabolic engineer-
ing target to improve the existing L-Phe production
strain.
However, the identification of emp5 (see Figures 3 and
4) as a promising metabolic engineering target as such
is not sufficiently unequivocal, because emp5 codes for
the net flux of PykA/PykF and the conversely directed
Pps reaction. Furthermore, the question should be ad-
dressed of why this flux even deteriorated, showing
increasing net fluxes during the observed phases (see
Figures 2 and 3). Therefore, a working hypothesis is
derived taking into account that increasing net fluxes
indicate rising PykA/PykF rates together with decreasing
Pps rates.
In the case of PykA/PykF, FBP (and to a minor extent
G6P and Ri5P) activates the kinase activity (Valle et al.,
1996). Provided that increasing glycolytic fluxes (see
absolute flux values in Table 1) also entailed increasing
FBP pool sizes because of underlying Michelis-Menten-
type reaction kinetics, an increase in pyruvate kinase
activity would be the consequence. Furthermore, Pps
activity can be inhibited by tca metabolites such as
2-oxoglutarate (AKG) and oxaloacetate (OAA; Cooper and
Kornberg, 1974; Chulavatnatol and Atkinson, 1973), both
important precursors for amino acid synthesis, which was
not active in the nongrowing E. coli cells of this study.
Figure 3. Flux difference ¢ is calculated as the difference
between the experimentally determined flux [mol % of glucose
uptake] during the production phase and the corresponding flux
at optimum carbon flux distribution as shown in Figure 2. Flux
maps refer to the half-time of each labeling period. For flux
abbreviations, see Figure 2 and Table 5.
Figure 4. Maximum achievable L-Phe flux [mol %] based on
the assumption that one observed flux (emp5, ppp1, ppp4, or
ppp6 of phase A) could not be modified. The glucose uptake was
kept constant (upt ) 1), and the rest of the metabolic network
could reroute carbon fluxes such that a maximum L-Phe
formation is achieved. The straight line indicates the upper 59.7
mol % L-Phe optimum, which is reachable according to the linear
programming results presented in Figure 2.
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Regarding the increased, absolute tca fluxes and follow-
ing the same argumentation as above, a diminished Pps
activity would be the consequence.
Hence, deteriorating L-Phe/glucose levels could be
caused by decreasing Pps activity together with increas-
ing PykA/PykF activity, both regulated on a biochemical
level by enzyme inhibition and/or activation, respectively.
pps overexpression could thus be an appropriate means
to compensate a potential Pps inhibition and to redirect
the PykA/PykF flux. However, total flux redirection from
PYR to PEP (as proposed by linear optimization) could
only be achieved if pykA and pykF would be completely
inactivated in resting cells.
Summary
Compared to the previously estimated maximum DAHP/
glucose yield of 86 mol % (Patnaik et al., 1995), these
linear programming studies estimate maximum L-Phe/
glucose yields of about 60 mol %, which is clearly a
consequence of the additional PEP needed for L-Phe
synthesis. While early works with DAHP-producing
strains succeeded to convert glucose to DAHP with
(almost) theoretical yields (Liao et al., 1996), our flux
analysis results show that the L-Phe producing E. coli
strain only reaches a third of the maximum L-Phe/glucose
yield during the L-tyrosine-limited production period.
Therefore, the Sensor reactor was applied in three
subsequent observation periods from 14 to 23.3 h process
time to elucidate whether and how the resulting serial
flux patterns give rise to the identification of metabolic
engineering targets for further strain improvement.
Most strikingly, it was found that the observed carbon
flux distributions were far from an optimal flux pattern
with respect to L-Phe production (at all times), especially
because the net flux via PykA/PykF and Pps steadily
increased, which entailed reducing L-Phe formation rates
from 20 to 11 mol %.
Thanks to the time-variant flux analysis patterns
observed, it was thus possible to formulate working
hypotheses considering the basic characteristics of the
enzyme kinetics involved. Hence, the maybe unexpected
hypothesis is formulated that increasingly high intr-
acellular oxaloacetate and 2-oxoglutarate levels presum-
ably cause Pps inhibition, which coincides with PykA/
PykF activation due to increased FBP levels. Hence, pps
overexpression in combination with (at least partly)
inactivation of pykA and/or pykF would be a promising
way to optimize L-Phe formation in the current produc-
tion strain. However, to validate this working hypothesis,
detailed measurements of in vivo metabolite concentra-
tions have to be performed, thus leading to a concerted
approach of serial metabolic flux analysis and metabolic
profiling studies in the future.
Notation
AcCoA acetyl-CoA
AKG R-keto glutarate, 2-oxoglutarate
CTR carbon dioxide transfer rate
DAHP 3-desoxy-arabino-heptulosonate-7-phosphate
DHS 3-dehydro shikimic acid
E4P D-erythrose 4-phosphate
F6P fructose-5-phosphate
FBP fructose-1,6-diphosphate
G6P glucose 6-phosphate
GAP glycerinaldehyde-3-phosphate
Gluc13C 1-13C-labeled glucose
GlucNat natively labeled glucose
ICIT iso-citrate
MAL malate
OAA oxaloacetate
OUR oxygen uptake rate
PEP phosphoenolpyruvate
Pps phosphoenolpyruvate synthase
pts phosphoenolpyruvate transfer system
PykA/PykF pyruvate kinase A, pyruvate kinase F
PYR pyruvate
Ri5P ribose-5-phosphate
Ru5P ribulose-5-phophate
S7P sedoheptulose-7-phosphate
SHI shikimic acid
SUC succinate
tal gene, coding for transaldolase
TCA tricarboxylic acid cycle
tkt gene, coding for transketolase
X5P xylose-5-phosphate
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